Table 2 Statistically significant fold-reductions in gene expression post-reovirus administration (n = 5 patients)
From: Immune characterization of metastatic colorectal cancer patients post reovirus administration
Fold decreases vs. PRE/baseline value; p < 0.001 | |||
|---|---|---|---|
48 h | D8 | D15 | |
VEGFA | 2 | ||
CXCR2 | 2 | ||
GZMA | 2 | 2 | |
ITGAM | 3 | ||